HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan Double-Digit Consumer Products Gain Drives Fragrance Sales

This article was originally published in The Rose Sheet

Executive Summary

A double-digit local currency gain in Givaudan's consumer products business was the key driver of growth in the fragrance division in 2002, the Geneva, Switzerland-based flavors and fragrance supplier reported in a March 5 1sales and earnings release

You may also be interested in...



Parsol production

Roche Vitamins will transition production of its Parsol UV filters to LC United in Taiwan. Long-term agreement ends seven-year relationship with Givaudan. Parsol filters will cease production in Givaudan's Vernier, Switzerland facility by the end of 2003, Roche says. Agreement with LC United involves manufacture of the UVA/UVB filter Parsol 1789 and UVB filters Parsol, MCX, Parsol 5000, Parsol 340 and Parsol HS. Collaboration will provide Roche with opportunity to broaden its range of UV protection solutions, Roche adds. LC facility will deliver materials conforming to the existing Roche specifications, firm notes...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011030

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel